Redburn starts Domino’s with Sell on heavy GLP-1 exposure
As previously reported, Redburn Atlantic initiated coverage of Domino’s Pizza (DPZ) with a Sell rating and $340 price target Domino’s faces the heaviest pressure from GLP-1 weight loss drug adoption, with high exposure to dinner occasions and lower-income consumers, the analyst tells investors in a research note. The firm says the company’s organic traffic remains weak, with carryout far outpacing delivery. With system sales growth challenged and consensus expectations still elevated, there is downside risk for Domino’s, contends Redburn.
Confident Investing Starts Here:
-
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
-
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. >;elm:context_link;itc:0;sec:content-canvas" href="https://thefly.com/?utm_source=finance.yahoo.com&utm_medium=referral" rel="nofollow noopener" target="_blank">Try Now>>
Read More on DPZ:
Latest News
- Bitdeer Ramps Up Self-Mining Capacity, Ships 1.6 EH/s of SEALMINER A2s in May
- Wall Street’s Risk-On Trade Gets Green Light from CPI
- Trump Tax Bill Splits Solar Market. Residential Power Is ‘on the Chopping Block.’
- UBS Remains Neutral on Brown-Forman Corporation (BF-B), Trims PT to $30
- Here's How Much Traders Expect Oracle Stock to Move After Earnings
- UBS Maintains Neutral Rating on International Flavors & Fragrances Inc. (IFF), PT $83